open access

Vol 3, No 3 (2007)
Guidelines / Expert consensus
Published online: 2007-05-24
Get Citation

Recommendations on the management of prostate cancer - a round table conference

Elżbieta Senkus-Konefka, Artur Antoniewicz, Andrzej Borkowski, Andrzej Borówka, Tomasz Demkow, Jakub Dobruch, Jacek Fijuth, Jacek Jassem, Maciej Krzakowski, Marcin Ligaj, Bogusław Maciejewski, Włodzimierz T. Olszewski, Piotr Siedlecki, Romuald Zdrojowy
Onkol. Prak. Klin 2007;3(3):103-119.

open access

Vol 3, No 3 (2007)
EXPERTS' OPINION
Published online: 2007-05-24

Abstract

Prostate cancer is one of the most common male malignancies in most European countries and the US. A significant increase in the number of new cases has been observed over the last years, most probably due to increase in the life span and introduction of PSA in the 1980s. Two main treatment modalities of early prostate cancer are surgery and radiotherapy. In selected patients with short life expectancy and low histological grade of the tumor, watchful waiting is acceptable. Treatment of advanced prostate cancer is based on inhibition of stimulatory effect of androgens on prostate cancer cells. Androgen ablation allows for subjective improvement, PSA decrease and objective tumor regression in 80% of patients. High incidence of prostate cancer and unsatisfactory results of its treatment created a demand for uniform, evidence-based diagnostic and therapeutic guidelines. Recommendations presented in this paper were prepared during a round table meeting of experts in urology, oncology and pathology, and updated with most current literature data.

Abstract

Prostate cancer is one of the most common male malignancies in most European countries and the US. A significant increase in the number of new cases has been observed over the last years, most probably due to increase in the life span and introduction of PSA in the 1980s. Two main treatment modalities of early prostate cancer are surgery and radiotherapy. In selected patients with short life expectancy and low histological grade of the tumor, watchful waiting is acceptable. Treatment of advanced prostate cancer is based on inhibition of stimulatory effect of androgens on prostate cancer cells. Androgen ablation allows for subjective improvement, PSA decrease and objective tumor regression in 80% of patients. High incidence of prostate cancer and unsatisfactory results of its treatment created a demand for uniform, evidence-based diagnostic and therapeutic guidelines. Recommendations presented in this paper were prepared during a round table meeting of experts in urology, oncology and pathology, and updated with most current literature data.
Get Citation

Keywords

prostate cancer; diagnosis; treatment

About this article
Title

Recommendations on the management of prostate cancer - a round table conference

Journal

Oncology in Clinical Practice

Issue

Vol 3, No 3 (2007)

Article type

Guidelines / Expert consensus

Pages

103-119

Published online

2007-05-24

Bibliographic record

Onkol. Prak. Klin 2007;3(3):103-119.

Keywords

prostate cancer
diagnosis
treatment

Authors

Elżbieta Senkus-Konefka
Artur Antoniewicz
Andrzej Borkowski
Andrzej Borówka
Tomasz Demkow
Jakub Dobruch
Jacek Fijuth
Jacek Jassem
Maciej Krzakowski
Marcin Ligaj
Bogusław Maciejewski
Włodzimierz T. Olszewski
Piotr Siedlecki
Romuald Zdrojowy

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl